Cadrenal Therapeutics, Inc. Common Stock (CVKD) vs WORK Medical Technology Group Ltd. Class A (WOK)

A side-by-side comparison of Cadrenal Therapeutics, Inc. Common Stock and WORK Medical Technology Group Ltd. Class A across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cadrenal Therapeutics, Inc. Common Stock logo
CVKD
Cadrenal Therapeutics, Inc. Common Stock
$4M
$0.99HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
WORK Medical Technology Group Ltd. Class A logo
WOK
WORK Medical Technology Group Ltd. Class A
$4M
$1.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — CVKD vs WOK

growth of $100 · dividends reinvested · last 2y
CVKD -87.1% (-64.2%/yr)WOK -100.0% (-99.9%/yr)CVKD compounded faster over this window
Log scale — wide-divergence pair
000001101001kStart $10020252026$13$0
CVKD WOK

CVKD vs WOK: by the numbers

  • •WOK is the larger company ($4M vs $4M market cap).
  • •Both run net losses; CVKD's is the smaller (0.00% vs -10.89% net margin).

Metrics side by side

Valuation

MetricCVKDWOK
P/B ratio0.860.12

Profitability

MetricCVKDWOK
Gross margin0.00%23.81%
Operating margin0.00%-25.34%
Net margin0.00%-10.89%
ROE-282.13%-5.85%
ROIC-284.81%-9.04%

Growth (annualized)

MetricCVKDWOK
Revenue CAGR (5Y)N/A-28.44%

Go deeper

Full CVKD analysisFull WOK analysisInteractive comparison tool

Dig into the metrics

Cadrenal Therapeutics, Inc. Common Stock ROEWORK Medical Technology Group ROECadrenal Therapeutics, Inc. Common Stock operating marginWORK Medical Technology Group operating marginCadrenal Therapeutics, Inc. Common Stock revenue growthWORK Medical Technology Group revenue growthCadrenal Therapeutics, Inc. Common Stock free cash flowWORK Medical Technology Group free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.